These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10478581)

  • 1. An enzyme-linked immunosorbent assay for antibodies against acid soluble skeletal muscle antigen in myasthenia gravis.
    Annamma M; Sarada C; Radhakrishnan VV
    Acta Neurol Scand; 1999 Sep; 100(3):175-7. PubMed ID: 10478581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for detection of antibodies to extractable muscle antigens in myasthenia gravis.
    Viana VS; Bueno C; Marchiori PE; Oliveira RM; Assis JL; Scaff M; Cossermelli W
    Acta Neurol Scand; 1986 Jun; 73(6):599-601. PubMed ID: 3751500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
    Chen XJ; Qiao J; Xiao BG; Lu CZ
    J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: comparison with indirect immunofluorescence.
    Carrano JA; Swanson NR; Dawkins RL
    J Immunol Methods; 1983 May; 59(3):301-14. PubMed ID: 6343491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
    Aarli JA; Gilhus NE; Hofstad H
    Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
    Hofstad H; Ulvestad E; Gilhus NE; Matre R; Aarli JA
    Acta Neurol Scand; 1992 Apr; 85(4):233-8. PubMed ID: 1585794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma.
    Husain AM; Massey JM; Howard JF; Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():471-4. PubMed ID: 9668277
    [No Abstract]   [Full Text] [Related]  

  • 9. An enzyme-linked immunosorbent assay for antibodies against saline-soluble muscle components in myasthenia gravis.
    Akazawa S; Furukawa S; Kamo I; Furukawa Y; Satoyoshi E; Hayashi K
    J Immunol Methods; 1986 Nov; 94(1-2):161-7. PubMed ID: 3782808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
    Kuks JB; Limburg PC; Horst G; Dijksterhuis J; Oosterhuis HJ
    J Neurol Sci; 1993 Nov; 119(2):183-8. PubMed ID: 8277333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to skeletal muscle in myasthenia gravis. Part 2. Prevalence in non-thymoma patients.
    Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
    J Neurol Sci; 1993 Dec; 120(1):78-81. PubMed ID: 8289082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart muscle antibodies in myasthenia gravis.
    Mygland A; Aarli JA; Hofstad H; Gilhus NE
    Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum anti-titin antibody in patients with myasthenia gravis].
    Li YF; Zhang JB; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
    Takamori M; Motomura M; Kawaguchi N; Nemoto Y; Hattori T; Yoshikawa H; Otsuka K
    Neurology; 2004 May; 62(10):1894-6. PubMed ID: 15159506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.